Delivery Order SPE2DR25D2104-SPE2DR26F3VAA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,384.52. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and represents a non-set-aside competitive award. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.80 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count packaging) on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,162.38 and ultimate completion date of January 9, 2026. This non-set-aside contract represents a competitively awarded task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency awarded a delivery order valued at $27,146.46 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on December 4, 2025, with a completion date of December 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $17,169.04 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count) on July 17, 2025, with a completion date of July 18, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $1,264.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a first-line antibiotic commonly used in the treatment of tuberculosis and other...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3VAADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,231.29 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on February 3, 2026, with an ultimate completion date of February 4, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating full and open competition. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent entity, Cencora, Inc.'s, significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supplies to support military healthcare programs globally. Rifampin is an antimicrobial agent commonly used in the treatment of tuberculosis and other mycobacterial infections within military and federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor, has demonstrated consistent capability to fulfill federal medical procurement requirements through its extensive portfolio of competitive contract awards with the Defense Logistics Agency and other government agencies. The company's operations under the DLA Troop Support Medical IDC enable it to supply critical pharmaceutical commodities, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military treatment facilities and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/2/26 |